Total Valuation
Mosaic ImmunoEngineering has a market cap or net worth of $4.88M. The enterprise value is $6.37M.
Market Cap$4.88M
Enterprise Value$6.37M
Share Statistics
Mosaic ImmunoEngineering has 7,242,137 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,242,137
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mosaic ImmunoEngineering’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 10.60%.
Return on Equity (ROE)0.09
Return on Assets (ROA)-34.60
Return on Invested Capital (ROIC)10.60%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee0.00
Profits Per Employee-343.92K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mosaic ImmunoEngineering is ―. Mosaic ImmunoEngineering’s PEG ratio is 0.12.
PE Ratio―
PS Ratio0.00
PB Ratio-0.30
Price to Fair Value-0.30
Price to FCF-20.20
Price to Operating Cash Flow-29.23
PEG Ratio0.12
Income Statement
In the last 12 months, Mosaic ImmunoEngineering had revenue of 0.00 and earned -687.85K in profits. Earnings per share was -0.10.
Revenue0.00
Gross Profit0.00
Operating Income-616.12K
Pretax Income-685.45K
Net Income-687.85K
EBITDA-616.12K
Earnings Per Share (EPS)-0.10
Cash Flow
In the last 12 months, operating cash flow was -166.84K and capital expenditures 0.00, giving a free cash flow of -166.84K billion.
Operating Cash Flow-166.84K
Free Cash Flow-166.84K
Free Cash Flow per Share-0.02
Dividends & Yields
Mosaic ImmunoEngineering pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.08
52-Week Price Change25.28%
50-Day Moving Average0.66
200-Day Moving Average0.61
Relative Strength Index (RSI)52.31
Average Volume (3m)1.50K
Important Dates
Mosaic ImmunoEngineering upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Mosaic ImmunoEngineering as a current ratio of <0.01, with Debt / Equity ratio of -19.39%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.74
Net Debt to EBITDA-2.70
Interest Coverage Ratio-7.39
Taxes
In the past 12 months, Mosaic ImmunoEngineering has paid 2.40K in taxes.
Income Tax2.40K
Effective Tax Rate>-0.01
Enterprise Valuation
Mosaic ImmunoEngineering EV to EBITDA ratio is -6.35, with an EV/FCF ratio of -35.12.
EV to Sales0.00
EV to EBITDA-6.35
EV to Free Cash Flow-35.12
EV to Operating Cash Flow-35.12
Balance Sheet
Mosaic ImmunoEngineering has $72.00 in cash and marketable securities with $1.48M in debt, giving a net cash position of -$1.48M billion.
Cash & Marketable Securities$72.00
Total Debt$1.48M
Net Cash-$1.48M
Net Cash Per Share-$0.20
Tangible Book Value Per Share-$1.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mosaic ImmunoEngineering is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast16.34%